Weiss Multi Strategy Advisers LLC Curis Inc Transaction History

Weiss Multi Strategy Advisers LLC

  • $0
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$0.62 - $2.25 $16,514 - $59,933
-26,637 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$1.38 - $1.94 $162 - $228
118 Added 0.44%
26,637 $47,000
Q2 2018

Aug 14, 2018
BUY
$1.73 - $3.35 $45,877 - $88,838
26,519 New
26,519 $46,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email